R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.
Saved in:
| Title: | R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial. |
|---|---|
| Authors: | Kibwana E; Centre for Geographic Medicine Research, Coast, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Bundi C; Centre for Geographic Medicine Research, Coast, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Kimani D; Centre for Geographic Medicine Research, Coast, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Nyamako L; Centre for Geographic Medicine Research, Coast, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Keter K; Centre for Geographic Medicine Research, Coast, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Mutiso A; Centre for Geographic Medicine Research, Coast, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Ogwang R; Centre for Geographic Medicine Research, Coast, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Bellamy D; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Rapi K; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Bajer A; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Provstgaard-Morys S; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Stockdale L; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Munoz O; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Datoo MS; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Lawrie A; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Ramos-Lopez F; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Roberts R; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Hamaluba M; Centre for Geographic Medicine Research, Coast, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University Oxford, Oxford, United Kingdom., Hill AVS; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Bejon P; Centre for Geographic Medicine Research, Coast, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University Oxford, Oxford, United Kingdom., Ewer KJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Kapulu M; Centre for Geographic Medicine Research, Coast, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University Oxford, Oxford, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Jul 07; Vol. 16, pp. 1620365. Date of Electronic Publication: 2025 Jul 07 (Print Publication: 2025). |
| Publication Type: | Journal Article; Clinical Trial, Phase II |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
